Biolife Solutions (BLFS) Equity Ratio (2010 - 2026)

Biolife Solutions (BLFS) has 17 years of Equity Ratio data on file, last reported at 0.93 in Q1 2026.

• Equity Ratio for Q1 2026 came in at 0.93, up 4.04% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.93 (up 4.04% YoY), and the FY2025 annual result was 0.92, up 4.91% from the prior year.
• Equity Ratio improved to 0.93 in Q1 2026 per BLFS's latest filing, from 0.92 in the prior quarter.
• Over five years, Equity Ratio peaked at 0.93 in Q1 2026 and troughed at 0.8 in Q1 2023.
• A 5-year average of 0.86 and a median of 0.86 in 2024 frame the typical range for Equity Ratio.
• The sharpest annual moves came in 2023 and 2025: Equity Ratio slipped 8.3% in 2023, then grew 7.49% in 2025.
• A 5-year view of Equity Ratio shows it stood at 0.81 in 2022, then advanced by 1.14% to 0.82 in 2023, then grew by 6.75% to 0.87 in 2024, then gained by 4.91% to 0.92 in 2025, then grew by 1.33% to 0.93 in 2026.
• Business Quant data shows BLFS's Equity Ratio at 0.93 in Q1 2026, 0.92 in Q4 2025, and 0.9 in Q3 2025.